157 related articles for article (PubMed ID: 36917553)
1. Perspective on high-throughput bioanalysis to support
Santiago BG; Eisennagel SH; Peckham GE; Liebhardt AM; Alburn CL; Roethke TJ; Reilly MA; Sydor JR; Karlinsey MZ
Bioanalysis; 2023 Feb; 15(3):177-191. PubMed ID: 36917553
[TBL] [Abstract][Full Text] [Related]
2. Recent development in software and automation tools for high-throughput discovery bioanalysis.
Shou WZ; Zhang J
Bioanalysis; 2012 May; 4(9):1097-109. PubMed ID: 22612689
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in software tools for high-throughput in vitro ADME support with high-resolution MS.
Paiva A; Shou WZ
Bioanalysis; 2016 Aug; 8(16):1723-33. PubMed ID: 27487387
[TBL] [Abstract][Full Text] [Related]
4. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
Shou WZ; Zhang J
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
[TBL] [Abstract][Full Text] [Related]
5. An ultrafast and flexible liquid chromatography/tandem mass spectrometry system paves the way for machine learning driven in vivo sample processing in early drug discovery.
Häbe TT; Späth C; Schrade S; Jörg W; Süssmuth RD; Bischoff D; Luippold AH
Rapid Commun Mass Spectrom; 2021 Jun; 35(12):e9096. PubMed ID: 33837598
[TBL] [Abstract][Full Text] [Related]
6. Increasing high-throughput discovery bioanalysis using automated selected reaction monitoring compound optimization, ultra-high-pressure liquid chromatography, and single-step sample preparation workflows.
Smalley J; Xin B; Olah TV
Rapid Commun Mass Spectrom; 2009 Nov; 23(21):3457-64. PubMed ID: 19813283
[TBL] [Abstract][Full Text] [Related]
7. Integrity and efficiency: AbbVie's journey of building an integrated nonregulated bioanalytical laboratory.
Wang YT; Maes EM; Heinle L; Ruterbories K; Doktor S; Larsen M; Olson A; Lee A; Van Handel C; Ji QC; Desino K; Jenkins GJ
Bioanalysis; 2023 Feb; 15(3):161-176. PubMed ID: 36961367
[TBL] [Abstract][Full Text] [Related]
8. Flexible End2End Workflow Automation of Hit-Discovery Research.
Holzmüller-Laue S; Göde B; Thurow K
J Lab Autom; 2014 Aug; 19(4):349-61. PubMed ID: 24464814
[TBL] [Abstract][Full Text] [Related]
9. Standardized workflows for increasing efficiency and productivity in discovery stage bioanalysis.
Bateman KP; Cohen L; Emary B; Pucci V
Bioanalysis; 2013 Jul; 5(14):1783-94. PubMed ID: 23862710
[TBL] [Abstract][Full Text] [Related]
10. Development of a high-speed, multiplexed sample-delivery instrument for LC-MS/MS bioanalysis.
Janiszewski J; Schneider R; Kapinos B; West M; Funk C; Federico J; Umland J; Piotrowski M; Mitchell W; Zhang H; Zelesky V; Gobey J; Whalen K; Liston T; Troutman M
Bioanalysis; 2012 May; 4(9):1039-56. PubMed ID: 22612685
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on bioanalytical mass spectrometry and automation in drug discovery.
Janiszewski JS; Liston TE; Cole MJ
Curr Drug Metab; 2008 Nov; 9(9):986-94. PubMed ID: 18991596
[TBL] [Abstract][Full Text] [Related]
12. Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS.
Ranasinghe A; Ramanathan R; Jemal M; D'Arienzo CJ; Humphreys WG; Olah TV
Bioanalysis; 2012 Mar; 4(5):511-28. PubMed ID: 22409550
[TBL] [Abstract][Full Text] [Related]
13. Data processing for high-throughput mass spectrometry in drug discovery.
Liu C; Zhang H
Expert Opin Drug Discov; 2024 Jul; 19(7):815-825. PubMed ID: 38785418
[TBL] [Abstract][Full Text] [Related]
14. A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen.
Kieltyka K; Zhang J; Li S; Vath M; Baglieri C; Ferraro C; Zvyaga TA; Drexler DM; Weller HN; Shou WZ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1579-91. PubMed ID: 19399765
[TBL] [Abstract][Full Text] [Related]
15. Software automation tools for increased throughput metabolic soft-spot identification in early drug discovery.
Zelesky V; Schneider R; Janiszewski J; Zamora I; Ferguson J; Troutman M
Bioanalysis; 2013 May; 5(10):1165-79. PubMed ID: 23721441
[TBL] [Abstract][Full Text] [Related]
16. Incurred sample reanalysis in drug discovery bioanalysis.
Giri P; Patel N; Joshi V; Giri S; Srinivas NR
Biomed Chromatogr; 2019 Mar; 33(3):e4430. PubMed ID: 30412644
[TBL] [Abstract][Full Text] [Related]
17. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.
Zhang J; Shou WZ; Vath M; Kieltyka K; Maloney J; Elvebak L; Stewart J; Herbst J; Weller HN
Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3593-601. PubMed ID: 21080511
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a novel ultra fast metabolic stability analysis method using exact mass TOF-MS.
Manna JD; Richardson SJ; Moghaddam MF
Bioanalysis; 2017 Feb; 9(4):359-368. PubMed ID: 28074669
[TBL] [Abstract][Full Text] [Related]
19. A high-speed liquid chromatography/tandem mass spectrometry platform using multiplexed multiple-injection chromatography controlled by single software and its application in discovery ADME screening.
Zhang J; Vath M; Ferraro C; Li Y; Murphy K; Zvyaga T; Weller H; Shou W
Rapid Commun Mass Spectrom; 2013 Apr; 27(7):731-7. PubMed ID: 23495019
[TBL] [Abstract][Full Text] [Related]
20. Bioanalytical strategies in drug discovery and development.
Thakur A; Tan Z; Kameyama T; El-Khateeb E; Nagpal S; Malone S; Jamwal R; Nwabufo CK
Drug Metab Rev; 2021 Aug; 53(3):434-458. PubMed ID: 34310243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
